InvestorsHub Logo
Followers 1042
Posts 28953
Boards Moderated 0
Alias Born 11/22/2009

Re: None

Sunday, 01/10/2010 10:50:37 AM

Sunday, January 10, 2010 10:50:37 AM

Post# of 15766
ANX is keeping silent for a reason. Something positive is near. This has huge potential since what they are doing is removing current side affects of existing vaccines. This is a done deal for FDA to approve. Guys, remember when a year ago, HEB was trading under $1.00? By June, it hit a high of $4.61 on NO NEWS! They have a vaccine to treat CFS and their market was very limited but analyst were expecting $15.00 a share. Also, remember CTIC? They hit $2.00 based on what? Their CEO begun to sell all his shares and so did all management! In my eyes, ANX can eeasily hit $1.00 in NO TIME if not bought out yet. Their product has a current market and with FDA approval, their products would only increase in sales. This is a GEM like Toucan called it. Best of luck to all.

Finra